Armata Pharmaceuticals, Inc. (ARMP) Misses Q3 EPS by 24c
Tweet
Share
E-mailGet Alerts ARMP Hot Sheet
Join SI Premium – FREE
Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q3 EPS of ($0.74), $0.24 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $0 versus the consensus estimate of $1.38 million.
For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- NetApp (NTAP) Tops Q1 EPS by 47c, Beats on Revenue
- Fjordland Announces Consolidation
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
